Tolemy Bio lands €1.4M to power AI-driven cell biology

Cambridge-based biotech startup Tolemy Bio has raised €1.4 million in pre-seed funding to advance its AI-enabled technology for cell biology research and biopharma development. The round was led by Norrsken Evolve , with participation from Big Sur Ventures, JME Ventures, Masia, and a new UK-based stealth fund. Founded by Alex Ward and Caelan Anderson , Tolemy Bio is developing Orbit, a system designed to help researchers better understand, interpret, and optimise living cells used in modern ther